Mammotome

About Mammotome

Mammotome is a global leader in breast care technology, specializing in innovative diagnostic solutions for breast cancer. The company serves healthcare providers, including hospitals and clinics, by offering advanced biopsy systems and tissue markers that improve diagnostic accuracy and patient care. Operating in the medical device market, Mammotome's business model focuses on the development, manufacturing, and sale of cutting-edge breast biopsy technologies. Revenue is generated through the sale of these devices and related services, including training and support for medical professionals. As part of the Danaher family of companies, Mammotome benefits from exceptional leadership training and professional development programs, which contribute to its continuous innovation and market leadership. The company's commitment to reducing its environmental impact further underscores its dedication to corporate responsibility.